Of note, dysadherin deletion did not completely block ApcMin/+-driven intestinal tumorigenesis but delayed tumor development, as indicated by a decrease in tumor incidence in younger mice (6- and 8-week-old; Figure 1B). The gene discussed is FXYD5; the disease is neoplasm.